Human amniotic epithelial cells are reprogrammed more efficiently by induced pluripotency than adult fibroblasts

Cellular Reprogramming

Volumn 14, Issue 3, 2012, Pages 193-203

  Easley IV, Charles A ^a,b   Miki, Toshio ^c   Castro, Carlos A ^b   Ozolek, John A ^b,d   Minervini, Crescenzio F ^c   Ben Yehudah, Ahmi ^b   Schatten, Gerald P ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; KRUPPEL LIKE FACTOR 4; MITOCHONDRIAL DNA; MYC PROTEIN; NEUROGENIC DIFFERENTIATION FACTOR; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX2;

AMNION CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA METHYLATION; ECTODERM; ENDODERM; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; MESODERM; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEAR REPROGRAMMING; ONCOGENE C MYC; PLURIPOTENT STEM CELL; POINT MUTATION; PREPUCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROBLAST;

ADULT; AMNION; ANIMALS; CELLS, CULTURED; EFFICIENCY; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INFANT, NEWBORN; MALE; MICE; MICE, SCID; NUCLEAR REPROGRAMMING; PREGNANCY; PRIMARY CELL CULTURE;

EID: 84862235753     PISSN: 21524971     EISSN: 21524998     Source Type: Journal    
DOI: 10.1089/cell.2011.0106     Document Type: Article

References (45)

1. Aasen, T., Raya, A., Barrero, M.J., Garreta, E., Consiglio, A., Gonzalez, F., Vassena, R., Bilic, J., Pekarik, V., Tiscornia, G., et al. (2008). Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26, 1276-1284.
2. Aoi, T., Yae, K., Nakagawa, M., Ichisaka, T., Okita, K., Takahashi, K., Chiba, T., and Yamanaka, S. (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321, 699-702.
3. Araki, R., Jincho, Y., Hoki, Y., Nakamura, M., Tamura, C., Ando, S., Kasama, Y., and Abe, M. (2009). Conversion of ancestral fibroblasts to induced pluripotent stem cells. Stem Cells 28, 213-220.
4. Carey, B.W., Markoulaki, S., Beard, C., Hanna, J., and Jaenisch, R. (2010). Single-gene transgenic mouse strains for reprogramming adult somatic cells. Nat. Methods 7, 56-59.
5. Chan, E.M., Ratanasirintrawoot, S., Park, I.H., Manos, P.D., Loh, Y.H., Huo, H., Miller, J.D., Hartung, O., Rho, J., Ince, T.A., et al. (2009). Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat. Biotechnol. 27, 1033-1037.
6. Dimos, J.T., Rodolfa, K.T., Niakan, K.K., Weisenthal, L.M., Mitsumoto, H., Chung, W., Croft, G.F., Saphier, G., Leibel, R., Goland, R., et al. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221.
7. Ebert, A.D., Yu, J., Rose, F.F., Jr., Mattis, V.B., Lorson, C.L., Thomson, J.A., and Svendsen, C.N. (2009). Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277-280.
8. Galende, E., Karakikes, I., Edelmann, L., Desnick, R.J., Kerenyi, T., Khoueiry, G., Lafferty, J., McGinn, J.T., Brodman, M., Fuster, V., et al. (2010). Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. Cell. Reprogram. 12, 117-125.
9. Hanna, J., Wernig, M., Markoulaki, S., Sun, C.W., Meissner, A., Cassady, J.P., Beard, C., Brambrink, T., Wu, L.C., Townes, T.M., et al. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920-1923.
10. Hattori, K., Tanaka, M., Sugiyama, S., Obayashi, T., Ito, T., Satake, T., Hanaki, Y., Asai, J., Nagano, M., and Ozawa, T. (1991). Age-dependent increase in deleted mitochondrial DNA in the human heart: possible contributory factor to presbycardia. Am. Heart J. 121, 1735-1742.
11. Hattori, N., Nishino, K., Ko, Y.G., Hattori, N., Ohgane, J., Tanaka, S. and Shiota, K. (2004). Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J. Biol. Chem. 279, 17063-17069. (Pubitemid 38560461)
12. Hu, Q., Friedrich, A.M., Johnson, L.V., and Clegg, D. O. (2010). Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells 28, 1981-1991.
13. Jahangir Tafrechi, R.S., van de Rijke, F.M., Allallou, A., Larsson, C., Sloos, W.C., van de Sande, M., Wahlby, C., Janssen, G.M., and Raap, A.K. (2007). Single-cell A3243G mitochondrial DNA mutation load assays for segregation analysis. J. Histochem. Cytochem. 55, 1159-1166. (Pubitemid 350006298)
14. Kang, D., and Hamasaki, N. (2003). Mitochondrial oxidative stress and mitochondrial DNA. Clin. Chem. Lab. Med. 41, 1281-1288. (Pubitemid 37266115)
15. Kim, S.U., and de Vellis, J. (2009). Stem cell-based cell therapy in neurological diseases: A review. J. Neurosci. Res. 87, 2183-2200.
16. Kim, S.Y., Kim, M.J., Jung, H., Kim, W.K., Kwon, S.O., Son, M.J., Jang, I.S., Choi, J.S., Park, S.G., Park, B.C., et al. (2011). Comparative proteomic analysis of human somatic cells, induced pluripotent stem cells, and embryonic stem cells. Stem Cells Dev. Aug 29. [Epub ahead of print].
17. Li, C., Zhou, J., Shi, G., Ma, Y., Yang, Y., Gu, J., Yu, H., Jin, S., Wei, Z., Chen, F., et al. (2009). Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum. Mol. Genet. 18, 4340-4349.
18. Lister, R., Pelizzola, M., Kida, Y.S., Hawkins, R.D., Nery, J.R., Hon, G., Antosiewicz-Bourget, J., O'Malley, R., Castanon, R., Klugman, S., et al. (2011). Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68-73.
19. Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55-70.
20. Markoulaki, S., Hanna, J., Beard, C., Carey, B.W., Cheng, A.W., Lengner, C.J., Dausman, J.A., Fu, D., Gao, Q., Wu, S., et al. (2009). Transgenic mice with defined combinations of drug-inducible reprogramming factors. Nat. Biotechnol. 27, 169-171.
21. Meshorer, E., Yellajoshula, D., George, E., Scambler, P. J., Brown, D.T., and Misteli, T. (2006). Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev. Cell 10, 105-116. (Pubitemid 43025681)
22. Miki, T. (2011). Amnion-derived stem cells: in quest of clinical applications. Stem Cell Res. Ther. 2, 25.
23. Miki, T., Lehmann, T., Cai, H., Stolz, D.B., and Strom, S.C. (2005). Stem cell characteristics of amniotic epithelial cells. Stem Cells 23, 1549-1559. (Pubitemid 41741004)
24. Miki, T., Marongiu, F., Dorko, K., Ellis, E.C., and Strom, S.C. (2010). Isolation of amniotic epithelial stem cells. Curr. Protoc. Stem Cell Biol. Chapter 1, Unit 1E 3. Wiley Interscience.
25. Minervini, C.F., Izumi, M., and Miki, T. (2009). Effect of culture conditions on reference genes expression in placenta-derived stem cells. Int. J. Stem Cells 2, 69-75.
26. Momcilovic, O., Knobloch, L., Fornsaglio, J., Varum, S., Easley, C., and Schatten, G. (2010). DNA damage responses in human induced pluripotent stem cells and embryonic stem cells. PLoS One 5, e13410.
27. Muravchick, S. (2008). Clinical implications of mitochondrial disease. Adv. Drug Deliv. Rev. 60, 1553-1560.
28. Nakatsuji, N., Nakajima, F., and Tokunaga, K. (2008). HLAhaplotype banking and iPS cells. Nat. Biotechnol. 26, 739-740.
29. Okita, K., Ichisaka, T., and Yamanaka, S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317. (Pubitemid 47080336)
30. Park, I.H., Zhao, R., West, J.A., Yabuuchi, A., Huo, H., Ince, T.A., Lerou, P.H., Lensch, M.W., and Daley, G.Q. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146.
31. Pratama, G., Vaghjiani, V., Tee, J.Y., Liu, Y.H., Chan, J., Tan, C., Murthi, P., Gargett, C., and Manuelpillai, U. (2011). Changes in culture expanded human amniotic epithelial cells: implications for potential therapeutic applications. PLoS One 6, e26136.
32. Samavarchi-Tehrani, P., Golipour, A., David, L., Sung, H.K., Beyer, T.A., Datti, A., Woltjen, K., Nagy, A., and Wrana, J.L. (2010). Functional genomics reveals a BMP-driven mesenchymal- to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell. 7, 64-77.
33. Sohal, R.S., and Weindruch, R. (1996). Oxidative stress, caloric restriction, and aging. Science 273, 59-63. (Pubitemid 26255420)
34. Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G.W., Cook, E.G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009). Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964-977.
35. Sommer, C.A., Stadtfeld, M., Murphy, G.J., Hochedlinger, K., Kotton, D.N., and Mostoslavsky, G. (2009). Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27, 543-549.
36. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., and Hochedlinger, K. (2008). Induced pluripotent stem cells generated without viral integration. Science 322, 945-949.
37. Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. (Pubitemid 44233629)
38. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872. (Pubitemid 350138099)
39. Taylor, C.J., Bolton, E.M., Pocock, S., Sharples, L.D., Pedersen, R.A., and Bradley, J.A. (2005). Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366, 2019-2025. (Pubitemid 41773377)
40. Trovato, L., De Fazio, R., Annunziata, M., Sdei, S., Favaro, E., Ponti, R., Marozio, L., Ghigo, E., Benedetto, C., and Granata, R. (2009). Pluripotent stem cells isolated from human amniotic fluid and differentiation into pancreatic beta-cells. J. Endocrinol. Invest. 32, 873-876.
41. Varum, S., Rodrigues, A.S., Moura, M.B., Momcilovic, O., Easley, C.A.t., Ramalho-Santos, J., Van Houten, B., and Schatten, G. (2011). Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS One 6, e20914.
42. Warren, L., Manos, P.D., Ahfeldt, T., Loh, Y.H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z.D., Meissner, A., et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630.
43. Yakubov, E., Rechavi, G., Rozenblatt, S., and Givol, D. (2010). Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. Biochem. Biophys. Res. Commun. 394, 189-193.
44. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920.
45. Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., et al. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381-384.